Long-term oxygen therapy

Chest

Volumn 139, Issue 2, 2011, Pages 430-434

  Christopher, Kent L ^a   Porte, Phillip ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b National Association for Medical Direction of Respiratory Care   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; DEVICE; FEASIBILITY STUDY; HEALTH PROGRAM; HUMAN; HYPOXEMIA; LONG TERM CARE; MEDICAL ASSESSMENT; MEDICARE; MEDICOLEGAL ASPECT; OXYGEN THERAPY; PATIENT CARE; PATIENT EDUCATION; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE;

EID: 79551581782     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-0242     Document Type: Review

References (30)

1. Centers for Medicaid and Medicare Services. Medicare program, home health prospective payment system rate update for calendar year 2007 and deficit reduction act of 2005. Changes to Medicare payment for oxygen equipment and capped rental durable medical equipment; final rule. CMS, Office of the Actuary. 42 CFR; 414, 484, CMS-1304-F], RIN 0928-AN76.
2. Table V.7 Leading Medicare and Supplier BETOS, Classifications Based on Allowed Charges CY 2007-2008, Centers for Medicare and Medicaid Services/ORDI. Baltimore, MD: CMS Office of Research, Development and Information.
3. Problems in prescribing and supplying oxygen for Medicare patients. Am Rev Respir Dis. 1986;134(2):340-341.
4. Further recommendations for prescribing and supplying long-term oxygen therapy. Summary of the Second Conference on Long-Term Oxygen Therapy held in Denver, Colorado, December 11-12, 1987. Am Rev Respir Dis. 1988;138(3):745-747.
5. New problems in supply, reimbursement, and certification of medical necessity for long-term oxygen therapy. Summary of the Third Consensus Conference held in Washington, DC, March 15-16, 1990. Am Rev Respir Dis. 1990;142(3):721-724.
6. Petty TL, O'Donohue WJ Jr. Further recommendations for prescribing, reimbursement, technology development, and research in long-term oxygen therapy. Summary of the Fourth Oxygen Consensus Conference, Washington, DC, October 15-16, 1993. Am Rev Respir Dis. 1994;150(3):875-877.
7. Petty TL, Casaburi R. Recommendations of the Fifth Oxygen Consensus Conference. Writing and Organizing Committees. Respir Care. 2000;45(8):957-961.
8. Doherty DE, Petty TL. Recommendations of the 6th Long-Term Oxygen Consensus Conference. Writing and Organizing Committees. Respir Care. 2006;51(5):519-525.
9. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med. 1980;93(3):391-398.
10. Mularski RA, Asch SM, Shrank WH, et al. The quality of obstructive lung disease care for adults in the United States as measured by adherence to recommended processes. Chest. 2006;130(6):1844-1850.
11. Garcia-Aymerich J, Monsó E, Marrades RM, et al; EFRAM Investigators. Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study. Am J Respir Crit Care Med. 2001;164(6):1002-1007.
12. Kirschner N, Barr MS. Specialists/subspecialists and the patient-centered medical home. Chest. 2010;137(1):200-204.
13. Medicare Modernization Act, 42 USC 1395w-3 §302, Pub L No. 108-173 amended.
14. Giordano SP. Collateral damage. AARC Times. 2009;33(2):30.
15. Fed Regist. 2009;74(242):67227-67229.
16. Deficit Reduction Act, 42 USC 1395m(a)(5) §5101 (b), Pub L No. 109-171 amended.
17. Homecare Monday. 11,000 revoked, thousands more pull Medicare numbers. www.homecaremag.com. Accessed January 17, 2010.
18. Grant I, Heaton RK, McSweeny AJ, Adams KM, Timms RM. Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med. 1982;142(8):1470-1476. (Pubitemid 12048347)
19. Heaton RK, Grant I, McSweeny AJ, Adams KM, Petty TL. Psychologic effects of continuous and nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med. 1983;143(10):1941-1947. (Pubitemid 13007924)
20. Petty TL, Bliss PL. Ambulatory oxygen therapy, exercise, and survival with advanced chronic obstructive pulmonary disease (the Nocturnal Oxygen Therapy Trial revisited). Respir Care. 2000;45(2):204-211.
21. Dunne PJ. The clinical impact of new long-term oxygen therapy technology. Respir Care. 2009;54(8):1100-1111.
22. McCoy RW, Carlin BW. Product performance variability with home portable oxygen systems may impact patient performance outcomes: it may be the device, not the disease. Respir Care. 2009;54(3):324-326.
23. Department of Transportation Federal Aviation Administration. Use of additional portable oxygen concentrator devices on board aircraft. Fed Regist. 2010;75(3)739-742.
24. AARC. AARC clinical practice guideline. Oxygen therapy in the home or alternate site health care facility - 2007 revision & update. Respir Care. 2007;52(8):1063-1068.
25. Bliss PL, McCoy RW, Adams AB. Characteristics of demand oxygen delivery systems: maximum output and setting recommendations. Respir Care. 2004;49(2):160-165.
26. Bliss PL, McCoy RW, Adams AB. A bench study comparison of demand oxygen delivery systems and continuous flow of oxygen. Respir Care. 1999;44(8):925-931.
27. Palwai A, Skowronski M, Coreno A, Drummond C, McFadden ER. Critical comparisons of the clinical performance of oxygen conserving devices. Am J Respir Crit Care Med. 2010;181(10):1061-1071.
28. Tiep BL, Barnett J, Schiffman G, Sanchez O, Carter R. Maintaining oxygenation via demand oxygen delivery during rest and exercise. Respir Care. 2002;47(8):887-892.
29. Lewis DA. Sleep in patients with asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2001;7(2):105-112. (Pubitemid 32260653)
30. Christopher KL. Engaging patients in a collaborative care model. In: Dunne P, ed. Improving Symptom Control in Patients with Chronic Respiratory Disease. Grapevine, TX: American Association for Respiratory Care; 2009:15-19.